2023 Q1 Form 10-K Financial Statement

#000107023523000054 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2023
Revenue $151.0M $656.0M
YoY Change -18.38% -8.64%
Cost Of Revenue $51.00M $237.0M
YoY Change -16.39% -5.58%
Gross Profit $100.0M $419.0M
YoY Change -19.35% -10.28%
Gross Profit Margin 66.23% 63.87%
Selling, General & Admin $79.00M $340.0M
YoY Change 19.7% 14.48%
% of Gross Profit 79.0% 81.15%
Research & Development $45.00M $207.0M
YoY Change 0.0% -5.48%
% of Gross Profit 45.0% 49.4%
Depreciation & Amortization $20.00M $105.0M
YoY Change -41.18% -40.34%
% of Gross Profit 20.0% 25.06%
Operating Expenses $116.0M $1.144B
YoY Change -627.27% 143.92%
Operating Profit -$16.00M -$725.0M
YoY Change -110.96% 36150.0%
Interest Expense $6.000M $5.000M
YoY Change -700.0% -75.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$493.0M -$720.0M
YoY Change -440.0% -3889.47%
Income Tax $2.000M $14.00M
% Of Pretax Income
Net Earnings -$495.0M -$734.0M
YoY Change -443.75% -6216.67%
Net Earnings / Revenue -327.81% -111.89%
Basic Earnings Per Share -$1.27
Diluted Earnings Per Share -$0.85 -$1.35
COMMON SHARES
Basic Shares Outstanding 582.2M shares 578.7M shares
Diluted Shares Outstanding 639.5M shares

Balance Sheet

Concept 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $426.0M $426.0M
YoY Change -40.17% -40.17%
Cash & Equivalents $295.0M $295.0M
Short-Term Investments $131.0M $131.0M
Other Short-Term Assets $182.0M $182.0M
YoY Change 14.47% 14.47%
Inventory
Prepaid Expenses
Receivables $120.0M $120.0M
Other Receivables $15.00M $15.00M
Total Short-Term Assets $743.0M $743.0M
YoY Change -28.76% -28.76%
LONG-TERM ASSETS
Property, Plant & Equipment $25.00M $69.00M
YoY Change -39.02% -24.18%
Goodwill $595.0M
YoY Change -29.5%
Intangibles
YoY Change
Long-Term Investments $34.00M $34.00M
YoY Change 13.33% 13.33%
Other Assets $8.000M $35.00M
YoY Change -11.11% -5.41%
Total Long-Term Assets $936.0M $936.0M
YoY Change -38.58% -38.58%
TOTAL ASSETS
Total Short-Term Assets $743.0M $743.0M
Total Long-Term Assets $936.0M $936.0M
Total Assets $1.679B $1.679B
YoY Change -34.59% -34.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.00M $24.00M
YoY Change 9.09% 9.09%
Accrued Expenses $143.0M $143.0M
YoY Change -8.92% -8.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $367.0M $367.0M
YoY Change
Total Short-Term Liabilities $729.0M $729.0M
YoY Change 83.63% 83.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.000M $93.00M
YoY Change -75.0% -13.08%
Total Long-Term Liabilities $1.000M $93.00M
YoY Change -75.0% -84.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $729.0M $729.0M
Total Long-Term Liabilities $1.000M $93.00M
Total Liabilities $822.0M $822.0M
YoY Change -18.69% -18.69%
SHAREHOLDERS EQUITY
Retained Earnings -$2.028B
YoY Change 56.72%
Common Stock $2.909B
YoY Change 1.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $857.0M $857.0M
YoY Change
Total Liabilities & Shareholders Equity $1.679B $1.679B
YoY Change -34.59% -34.59%

Cashflow Statement

Concept 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$495.0M -$734.0M
YoY Change -443.75% -6216.67%
Depreciation, Depletion And Amortization $20.00M $105.0M
YoY Change -41.18% -40.34%
Cash From Operating Activities -$10.00M -$263.0M
YoY Change -211.11% 839.29%
INVESTING ACTIVITIES
Capital Expenditures $12.00M $7.000M
YoY Change -209.09% -12.5%
Acquisitions
YoY Change
Other Investing Activities $62.00M $217.0M
YoY Change -42.06% -11.79%
Cash From Investing Activities $50.00M $176.0M
YoY Change -47.92% -14.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.000M
YoY Change -40.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $6.000M
YoY Change -100.0% -40.0%
NET CHANGE
Cash From Operating Activities -10.00M -$263.0M
Cash From Investing Activities 50.00M $176.0M
Cash From Financing Activities 0.000 $6.000M
Net Change In Cash 40.00M -$84.00M
YoY Change -62.26% -144.68%
FREE CASH FLOW
Cash From Operating Activities -$10.00M -$263.0M
Capital Expenditures $12.00M $7.000M
Free Cash Flow -$22.00M -$270.0M
YoY Change -210.0% 650.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-02-28
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001070235
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 usd
CY2023 bbry Term Subscription Contract Duration
TermSubscriptionContractDuration
P4Y
CY2023 bbry Software Maintenance Revenue Term Io T
SoftwareMaintenanceRevenueTermIoT
P1Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023 bbry Share Based Compensation Arrangement By Share Based Payment Award Other Than Stock Options Award Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanStockOptionsAwardVestingPeriod
P3Y
CY2023Q1 bbry Number Of Endpoints Secured
NumberOfEndpointsSecured
500000000 endpoint
CY2023Q1 bbry Number Of Endpoints Secured Vehicles
NumberOfEndpointsSecuredVehicles
215000000 endpoint
CY2023 bbry Amount Of Options That Will Vest On Monthly Basis After Year1
AmountOfOptionsThatWillVestOnMonthlyBasisAfterYear1
0.75 shares
CY2023 bbry Tbrsu Share Limit
TBRSUShareLimit
1 shares
CY2023 bbry Pbrsu Share Limit
PBRSUShareLimit
1.5 shares
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2023Q1 us-gaap Government Assistance Statement Of Financial Position Extensible Enumeration
GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherReceivables
CY2022Q1 us-gaap Government Assistance Statement Of Financial Position Extensible Enumeration
GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherReceivables
CY2023 bbry Cews And Cers Final Extension Date Of Program
CEWSAndCERSFinalExtensionDateOfProgram
2021-10-23
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
3400000000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
582181485 shares
CY2023 dei Auditor Firm
AuditorFirmId
271
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Toronto, Canada
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
131000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120000000 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
12000000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
182000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
743000000 usd
CY2023Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
27000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
595000000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
844000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
522000000 usd
CY2023Q1 us-gaap Assets
Assets
1679000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143000000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
20000000 usd
CY2023Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
367000000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
175000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
729000000 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
40000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000 usd
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
0 usd
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
507000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
822000000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
576227898 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2909000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2028000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
857000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1679000000 usd
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
2529000000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1104000000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
20000000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44000000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000000 usd
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1504000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7000000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
857000000 usd
CY2021 us-gaap Revenues
Revenues
893000000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
250000000 usd
CY2021 us-gaap Gross Profit
GrossProfit
643000000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
215000000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
340000000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
297000000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
344000000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1144000000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
469000000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-725000000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2000000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
5000000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
21000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19000000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-734000000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
12000000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
2000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
1000000 usd
CY2021 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
13000000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20000000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-739000000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6000000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1084000000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176000000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
34000000 usd
CY2023 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2022 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
22000000 usd
CY2021 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
43000000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
6000000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-372000000 usd
CY2023 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
16000000 usd
CY2022 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
16000000 usd
CY2021 bbry Operating Lease Cash Flow
OperatingLeaseCashFlow
4000000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000000 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
5000000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18000000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44000000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000000 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-13000000 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
11000000 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-6000000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1000000 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4000000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1000000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-15000000 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-55000000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2000000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11000000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11000000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-16000000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9000000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5000000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-15000000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-29000000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-50000000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-79000000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-263000000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28000000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
82000000 usd
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
3000000 usd
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1000000 usd
CY2021 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5000000 usd
CY2023 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
0 usd
CY2022 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
35000000 usd
CY2021 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
0 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
34000000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31000000 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36000000 usd
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
514000000 usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
916000000 usd
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1039000000 usd
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 usd
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 usd
CY2021 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
24000000 usd
CY2023 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
CY2022 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
24000000 usd
CY2021 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1047000000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
207000000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65000000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10000000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19000000 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000 usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-84000000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
188000000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218000000 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
45875000 shares
CY2023 bbry Shares Issuedas Options Number Counted
SharesIssuedasOptionsNumberCounted
0.625 shares
CY2023 bbry Tbrsu Share Limit
TBRSUShareLimit
1 shares
CY2023 bbry Pbrsu Share Limit
PBRSUShareLimit
1.5 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements requires management to make estimates and assumptions with respect to the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. Significant areas requiring the use of management estimates relate to revenue-related estimates including variable consideration, standalone selling price (“SSP”), estimated customer life, if control of licenses to intellectual property has transferred, right of return and customer incentive commitments, fair value of reporting units in relation to actual or potential goodwill impairment, fair value of the Debentures (as defined in Note 6), fair value of share-based liability awards, fair value of long-lived assets in relation to actual or potential impairment, the Company’s long-lived asset groupings, estimated useful lives of property, plant and equipment and intangible assets, provision (or recovery) of income taxes, realization of deferred income tax assets and the related components of the valuation allowance, allowance for credit losses, incremental borrowing rates in determining the present value of lease liabilities and the determination of reserves for various litigation claims. Actual results could differ from these estimates, which were based upon circumstances that existed as of the date of the consolidated financial statements, February 28, 2023.</span></div>
CY2023 bbry Options Forfeited Numberof Shares Counted
OptionsForfeitedNumberofSharesCounted
0.625 shares
CY2023 bbry Rs Usforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
RSUsforfeitedsettledincashorsoldtocoverwithholdingtaxrequirementscountedas
1 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
11000000 shares
CY2019Q1 bbry Black Berry Cylance Plan Authorized Numberofshares
BlackBerryCylancePlanAuthorizedNumberofshares
9144176 shares
CY2023 bbry Options To Vest In Year1
OptionsToVestInYear1
0.25 shares
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2023 bbry Liability For Uncertain Tax Positions Percentage Minimum
LiabilityForUncertainTaxPositionsPercentageMinimum
0.50
CY2023 bbry Investments That Are Communicated To Third Party For Consideration Of Reasonableness Threshold Limit For Fair Value
InvestmentsThatAreCommunicatedToThirdPartyForConsiderationOfReasonablenessThresholdLimitForFairValue
0.005
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 usd
CY2023 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
4000000 usd
CY2021 bbry Impairment Of Long Lived Assets Held For Use Gross
ImpairmentOfLongLivedAssetsHeldForUseGross
46000000 usd
CY2021 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
37000000 usd
CY2021 bbry Impact Of Revaluation Of Certain Lease Liabilites
ImpactOfRevaluationOfCertainLeaseLiabilites
3000000 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
491000000 usd
CY2023 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
6000000 usd
CY2023 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
-10000000 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
487000000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
131000000 usd
CY2023Q1 us-gaap Long Term Investments
LongTermInvestments
34000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
27000000 usd
CY2022Q1 bbry Cash Cash Equivalents And Investments At Cost
CashCashEquivalentsAndInvestmentsAtCost
774000000 usd
CY2022 bbry Cash Cash Equivalents And Investments Unrealized Gains
CashCashEquivalentsAndInvestmentsUnrealizedGains
5000000 usd
CY2022 bbry Cash Cash Equivalents And Investments Unrealized Losses
CashCashEquivalentsAndInvestmentsUnrealizedLosses
-9000000 usd
CY2022Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
770000000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378000000 usd
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
334000000 usd
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
30000000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
28000000 usd
CY2023Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
34000000 usd
CY2022Q1 bbry Equity Investmentwithout Readily Determinable Fair Value
EquityInvestmentwithoutReadilyDeterminableFairValue
30000000 usd
CY2023 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2021 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
3000000 usd
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Cumulative Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
3000000 usd
CY2022 bbry Proceeds From Sale And Maturity Of Long Term Marketable Securities And Other Investments
ProceedsFromSaleAndMaturityOfLongTermMarketableSecuritiesAndOtherInvestments
35000000 usd
CY2022 us-gaap Proceeds From Limited Partnership Investments
ProceedsFromLimitedPartnershipInvestments
13000000 usd
CY2022 bbry Realized Gains Losses On Non Marketable Equity Investments Without Readily Determinable Fair Value Sold During The Period
RealizedGainsLossesOnNonMarketableEquityInvestmentsWithoutReadilyDeterminableFairValueSoldDuringThePeriod
22000000 usd
CY2023 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2022 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1000000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295000000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378000000 usd
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
214000000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
27000000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
28000000 usd
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
406000000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
364000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
364000000 usd
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
634000000 usd
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
634000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
0 usd
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
10000000 usd
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
1000000 usd
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
374000000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
364000000 usd
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
644000000 usd
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
635000000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1000000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000000 usd
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
10000000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-2000000 usd
CY2023Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Cecl Estimated Based On Days Past Due And Region
AccountsReceivableAllowanceForCreditLossRelatingToCECLEstimatedBasedOnDaysPastDueAndRegion
1000000 usd
CY2022Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Cecl Estimated Based On Days Past Due And Region
AccountsReceivableAllowanceForCreditLossRelatingToCECLEstimatedBasedOnDaysPastDueAndRegion
2000000 usd
CY2023Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Customers Evaluated Separately
AccountsReceivableAllowanceForCreditLossRelatingToCustomersEvaluatedSeparately
0 usd
CY2022Q1 bbry Accounts Receivable Allowance For Credit Loss Relating To Customers Evaluated Separately
AccountsReceivableAllowanceForCreditLossRelatingToCustomersEvaluatedSeparately
2000000 usd
CY2023Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
2
CY2022Q1 bbry Numberof Customers Witha Balance Greaterthan10of Total Accounts Receivable
NumberofCustomersWithaBalanceGreaterthan10ofTotalAccountsReceivable
0
CY2023 bbry Other Receivables Greater Than Five Percent Of Current Assets
OtherReceivablesGreaterThanFivePercentOfCurrentAssets
0 usd
CY2022 bbry Other Receivables Greater Than Five Percent Of Current Assets
OtherReceivablesGreaterThanFivePercentOfCurrentAssets
0 usd
CY2023Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
141000000 usd
CY2022Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
118000000 usd
CY2023Q1 bbry Other Current Assets Other Amounts
OtherCurrentAssetsOtherAmounts
41000000 usd
CY2022Q1 bbry Other Current Assets Other Amounts
OtherCurrentAssetsOtherAmounts
41000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
182000000 usd
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
159000000 usd
CY2022Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
118000000 usd
CY2023Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
141000000 usd
CY2022Q1 bbry Intellectual Property Included In Other Current Assets
IntellectualPropertyIncludedInOtherCurrentAssets
118000000 usd
CY2023 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2022 bbry Other Current Assets Greaterthanfivepercentof Current Assets
OtherCurrentAssetsGreaterthanfivepercentofCurrentAssets
0 other_current_asset
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
114000000 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
156000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89000000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25000000 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41000000 usd
CY2023 us-gaap Depreciation
Depreciation
12000000 usd
CY2022 us-gaap Depreciation
Depreciation
15000000 usd
CY2021 us-gaap Depreciation
Depreciation
21000000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2023Q1 bbry Cost Of Property Plant And Equipment Net Sold
CostOfPropertyPlantAndEquipmentNetSold
29000000 usd
CY2023Q1 bbry Accumulated Amortization Of Property Plant And Equipment Net Sold
AccumulatedAmortizationOfPropertyPlantAndEquipmentNetSold
18000000 usd
CY2023Q1 bbry Nbv Of Property Plant And Equipment Net Sold
NBVOfPropertyPlantAndEquipmentNetSold
11000000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
9000000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-4000000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1409000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1206000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1634000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1112000000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
522000000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
93000000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
161000000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
177000000 usd
CY2023 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
34000000 usd
CY2022 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
31000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
47000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
41000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
37000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
32000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
19000000 usd
CY2020Q1 us-gaap Goodwill
Goodwill
1437000000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 usd
CY2021 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
6000000 usd
CY2021Q1 us-gaap Goodwill
Goodwill
849000000 usd
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-5000000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
844000000 usd
CY2023 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-4000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
595000000 usd
CY2023 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 usd
CY2022 bbry Other Long Term Assets Greater Than Five Percent Of Total Assets
OtherLongTermAssetsGreaterThanFivePercentOfTotalAssets
0 usd
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
20000000 usd
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
20000000 usd
CY2023Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
24000000 usd
CY2022Q1 bbry Operating Lease Liabilities Current Included In Accruals
OperatingLeaseLiabilitiesCurrentIncludedInAccruals
28000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
99000000 usd
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
109000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143000000 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
157000000 usd
CY2023 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 usd
CY2022 bbry Other Accrued Liabilities Greaterthan Five Percentof Current Liabilities
OtherAccruedLiabilitiesGreaterthanFivePercentofCurrentLiabilities
0 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.265
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-191000000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5000000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-295000000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
125000000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9000000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
205000000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
10000000 usd
CY2022 bbry Effective Income Tax Rate Reconciliation Tax Credit Owing Investment Amount
EffectiveIncomeTaxRateReconciliationTaxCreditOwingInvestmentAmount
7000000 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
41000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
1000000 usd
CY2022 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-2000000 usd
CY2021 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-48000000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
10000000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000000 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
3000000 usd
CY2023 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
5000000 usd
CY2022 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
3000000 usd
CY2021 bbry Nondeductiblepermanentdifference
Nondeductiblepermanentdifference
13000000 usd
CY2023 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
65000000 usd
CY2022 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
0 usd
CY2021 bbry Difference In Income Taxes Resulting From Goodwill Impairment
DifferenceInIncomeTaxesResultingFromGoodwillImpairment
158000000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-128000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
133000000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-383000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-592000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-114000000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-730000000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19000000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1113000000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1000000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1000000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-2000000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
13000000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
8000000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-7000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
264000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
262000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
44000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
44000000 usd
CY2023Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2022Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2023Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
1000000 usd
CY2022Q1 bbry Deferred Tax Assets Convertible Debentures
DeferredTaxAssetsConvertibleDebentures
37000000 usd
CY2023Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
390000000 usd
CY2022Q1 bbry Deferred Tax Assets Researchand Development
DeferredTaxAssetsResearchandDevelopment
379000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
495000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
441000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
122000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
104000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1523000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1474000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1492000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1367000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
31000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
107000000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
31000000 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
107000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
31000000 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
107000000 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
125000000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1492000000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1367000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24000000 usd
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2000000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
4000000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
50000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20000000 usd
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24000000 usd
CY2023Q1 bbry Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
Unrecognizedtaxbenefitsnettedagainstdeferredincometaxes
21000000 usd
CY2023Q1 bbry Unrecognizedtaxbenefitsincludedwithintaxespayable
Unrecognizedtaxbenefitsincludedwithintaxespayable
0 usd
CY2023Q1 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
0 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3000000 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
3000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1910000000 usd
CY2023Q1 bbry Researchanddevelopmenttaxcredit
Researchanddevelopmenttaxcredit
482000000 usd
CY2023Q1 bbry Minimum Taxes
MinimumTaxes
207000000 usd
CY2023Q1 bbry Par Value Repurchase Percentage Changeof Control
ParValueRepurchasePercentageChangeofControl
1.15
CY2023Q1 bbry Ownership Percentageby Arms Length Party Common Shares
OwnershipPercentagebyArmsLengthPartyCommonShares
0.35
CY2023Q1 bbry Ownership Percentage Common Shares
OwnershipPercentageCommonShares
0.50
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
15000000 usd
CY2023 us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
quarterly
CY2023 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
2000000 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
487000000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
20000000 usd
CY2023 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
60800000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
728000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.70
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
97000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.59
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
142000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.71
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
489000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.63
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M26D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
489000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.63
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M26D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
489000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.63
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M26D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
23000000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
30000000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2023-11-03
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-734000000 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
12000000 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1104000000 usd
CY2023 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
138000000 usd
CY2022 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
212000000 usd
CY2021 bbry Debentures Fair Value Impact On Diluted Eps
DebenturesFairValueImpactOnDilutedEPS
0 usd
CY2023 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
6000000 usd
CY2022 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
6000000 usd
CY2021 bbry Interest Expense Debt On Diluted Eps
InterestExpenseDebtOnDilutedEPS
0 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-866000000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-194000000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1104000000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
578654000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570607000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
561305000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60833000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
60833000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
639487000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
631440000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
561305000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.97
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.97
CY2021Q1 bbry Number Of Exchanges Shares Remaining To Be Issued
NumberOfExchangesSharesRemainingToBeIssued
1421945 shares
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
25000000 usd
CY2023Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
17000000 usd
CY2022Q1 bbry Funds From Claim Filed With Ministry Of Innovation Science And Economic Development Canada Relating To Strategic Innovation Fund Program
FundsFromClaimFiledWithMinistryOfInnovationScienceAndEconomicDevelopmentCanadaRelatingToStrategicInnovationFundProgram
17000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2022Q3 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1000000 usd
CY2022Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
164000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2023 us-gaap Lessor Operating Lease Option To Terminate
LessorOperatingLeaseOptionToTerminate
one month
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
32000000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
37000000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
37000000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15000000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6000000 usd
CY2023 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
15000000 usd
CY2022 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
6000000 usd
CY2022 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
6000000 usd
CY2023 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
4000000 usd
CY2022 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
0 usd
CY2021 bbry Impairment Of Right Of Use Assets
ImpairmentOfRightOfUseAssets
37000000 usd
CY2023 us-gaap Sublease Income
SubleaseIncome
3000000 usd
CY2022 us-gaap Sublease Income
SubleaseIncome
3000000 usd
CY2021 us-gaap Sublease Income
SubleaseIncome
1000000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24000000 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52000000 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66000000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
76000000 usd
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
94000000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2022 bbry Government Subsidies
GovernmentSubsidies
46000000 usd
CY2023Q1 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
0 usd
CY2022Q1 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
8000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
26000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
10000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
82000000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6000000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
76000000 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 operatingsegment
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
207000000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219000000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
215000000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
340000000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
297000000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
344000000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
165000000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
182000000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
235000000 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
43000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
245000000 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
594000000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
6000000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
138000000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
212000000 usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-372000000 usd
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
165000000 usd
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2021 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-720000000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19000000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1113000000 usd
CY2023 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2022 us-gaap Revenues
Revenues
718000000 usd
CY2022 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2021 us-gaap Revenues
Revenues
893000000 usd
CY2021 bbry Percentage Of Revenue Attributable To Major Geographic Segments
PercentageOfRevenueAttributableToMajorGeographicSegments
1.000
CY2023 us-gaap Revenues
Revenues
656000000 usd
CY2022 us-gaap Revenues
Revenues
718000000 usd
CY2021 us-gaap Revenues
Revenues
893000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
214000000 usd
CY2023 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 usd
CY2022 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1000000 usd
CY2021 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2000000 usd
CY2023Q1 us-gaap Noncurrent Assets
NoncurrentAssets
867000000 usd
CY2023Q1 us-gaap Assets
Assets
1679000000 usd
CY2022Q1 us-gaap Noncurrent Assets
NoncurrentAssets
1457000000 usd
CY2022Q1 us-gaap Assets
Assets
2567000000 usd
CY2023 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2022 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2021 us-gaap Segment Reporting Disclosure Of Major Customers
SegmentReportingDisclosureOfMajorCustomers
one
CY2023 us-gaap Interest Paid Net
InterestPaidNet
6000000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
6000000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15000000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000 usd
CY2023 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
5000000 usd
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
6000000 usd
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
2000000 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
29000000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
25000000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
24000000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
0 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1000000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1000000 usd
CY2023Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.19
CY2023Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.24
CY2023Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.36
CY2022Q1 bbry Percentage Of Cash And Cash Equivalents Denominated In Foreign Currencies
PercentageOfCashAndCashEquivalentsDenominatedInForeignCurrencies
0.37
CY2022Q1 bbry Percentage Of Accounts Receivable Denominated In Foreign Currencies
PercentageOfAccountsReceivableDenominatedInForeignCurrencies
0.23
CY2022Q1 bbry Percentage Of Accrued Liabilities Denominated In Foreign Currencies
PercentageOfAccruedLiabilitiesDenominatedInForeignCurrencies
0.30
CY2023 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.12
CY2022 bbry Percent Of Cash Equivalents And Investments Threshold Used To Determine Major Issuers
PercentOfCashEquivalentsAndInvestmentsThresholdUsedToDetermineMajorIssuers
0.10
CY2023Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
1000000 usd
CY2022Q1 us-gaap Derivative Asset Fair Value Of Collateral
DerivativeAssetFairValueOfCollateral
0 usd
CY2023Q1 bbry Cash Cash Equivalents And Investments At Fair Value
CashCashEquivalentsAndInvestmentsAtFairValue
487000000 usd
CY2023 bbry Cews Subsidy Of Eligible Employees Insurable Remuneration
CEWSSubsidyOfEligibleEmployeesInsurableRemuneration
0.75
CY2023 bbry Cews Received After This Date Are Subject To Repayment If Certain Conditions Are Not Met
CEWSReceivedAfterThisDateAreSubjectToRepaymentIfCertainConditionsAreNotMet
2021-06-05
CY2023 bbry Cers Subsidy Of Eligible Fixed Property Expenses
CERSSubsidyOfEligibleFixedPropertyExpenses
0.65
CY2023 bbry Hhbrp Subsidy Of Eligible Expenses
HHBRPSubsidyOfEligibleExpenses
0.50
CY2023 bbry Government Subsidies
GovernmentSubsidies
4000000 usd

Files In Submission

Name View Source Status
0001070235-23-000054-index-headers.html Edgar Link pending
0001070235-23-000054-index.html Edgar Link pending
0001070235-23-000054.txt Edgar Link pending
0001070235-23-000054-xbrl.zip Edgar Link pending
bb-2282023x10kexhibit311.htm Edgar Link pending
bb-2282023x10kexhibit312.htm Edgar Link pending
bb-2282023x10kexhibit321.htm Edgar Link pending
bb-2282023x10kexhibit322.htm Edgar Link pending
bbfy23-consentxsedarxedg.htm Edgar Link pending
bbfy23-consentxsedarxedg001.jpg Edgar Link pending
bbry-20230228.htm Edgar Link pending
bbry-20230228.xsd Edgar Link pending
bbry-20230228_g1.jpg Edgar Link pending
exhibit21-bbsubsidiariesfe.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
projectbullet-psafullycomp.htm Edgar Link pending
psaexhibita-11.htm Edgar Link pending
psaexhibita-2.htm Edgar Link pending
bbry-20230228_cal.xml Edgar Link unprocessable
bbry-20230228_lab.xml Edgar Link unprocessable
bbry-20230228_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bbry-20230228_pre.xml Edgar Link unprocessable
bbry-20230228_htm.xml Edgar Link completed
psaexhibitb-1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending